Efficacy of Local Application of Platelet-Rich Plasma (PRP) on Mucosal Healing and Clinical Outcomes After Functional Endoscopic Sinus Surgery for Chronic Rhinosinusitis with Nasal Polyps: A Retrospective Cohort Study

Abstract

Background

Poor mucosal wound healing and recurrence of polyps remain significant challenges following functional endoscopic sinus surgery (FESS) for chronic rhinosinusitis with nasal polyps (CRSwNP). While platelet-rich plasma (PRP) shows regenerative potential in various fields, its rhinologic application remains understudied.

Objective

To evaluate the efficacy of local PRP application on postoperative time to epithelialization, endoscopic appearance, long-term recurrence, and quality of life in patients undergoing FESS for CRSwNP.

Methods

A retrospective cohort study was conducted on 120 CRSwNP patients undergoing FESS (2022-2025). The PRP group (n = 60) received intraoperative and postoperative local PRP application to the ethmoid cavity and middle meatus. The control group (n = 60) received standard care. The primary outcome was time to complete epithelialization. Secondary outcomes, assessed at scheduled intervals up to 48 weeks, included Lund–Kennedy Endoscopic Scores (LKES), SNOT-22, debridement frequency, 1-year polyp recurrence, and complications.

Results

Baseline demographics were comparable. The PRP group demonstrated a significantly shorter mean time to epithelialization compared to controls (3.4 ± 0.8 vs 5.1 ± 1.2 weeks, P < .001). Longitudinal analysis revealed better LKES in the PRP group at 8 (P = .012) and 12 weeks (P = .004). SNOT-22 score improvements were more pronounced in the PRP group at 3 months (P = .021). Crucially, the PRP group required significantly fewer postoperative debridements (1.5 ± 0.6 vs 2.8 ± 0.9, P < .001). The 1-year polyp recurrence rate (8.3% vs 23.3%, P = .024) and synechiae incidence (5.0% vs 16.7%, P = .041) were significantly lower in the PRP group.

Conclusion

Local application of autologous PRP accelerates mucosal epithelialization, reduces the need for postoperative debridement, decreases 1-year polyp recurrence, and improves early-to-intermediate endoscopic outcomes in CRSwNP patients. It represents an effective adjunctive therapy for enhancing functional recovery.

Keywords

chronic rhinosinusitis with nasal polyps endoscopic sinus surgery platelet-rich plasma mucosal healing regenerative medicine

Get full access to this article

View all access options for this article.

References

Rodriguez-Van Strahlen

Arancibia

Calvo-Henriquez

Mullol

Alobid

. Systematic review of long term sinonasal outcomes in CRSwNP after endoscopic sinus surgery: a call for unified and standardized criteria and terms. Curr Allergy Asthma Rep. 2024;24(8):443–456.

Martin-Jimenez

Moreno-Luna

. Long-term clinical outcomes in patients with chronic rhinosinusitis with nasal polyps associated with expanded types of endoscopic sinus surgery. J Clin Med. 2024;13(3):866.

Bogaert

Rheindorf

Dazert

. Quality of life in type 2 and non-type 2 endotypes in chronic rhinosinusitis with nasal polyps: a prospective trial. Clin Transl Allergy. 2025;15(6):e70070.

Hwang

Kim

Basurrah

Kim

. Efficacy of steroid-impregnated spacers after endoscopic Sinus surgery in chronic rhinosinusitis: a systematic review and meta-analysis. Clin Exp Otorhinolaryngol. 2023;16(2):148–158.

Kato

Peters

. Endotypes of chronic rhinosinusitis: relationships to disease phenotypes, pathogenesis, clinical findings, and treatment approaches. Allergy. 2022;77(3):812–826.

Avdeeva

Fokkens

. Precision medicine in chronic rhinosinusitis with nasal polyps. Curr Allergy Asthma Rep. 2018;18(4):25.

Wang

Duan

, et al. A diagnostic model for predicting type 2 nasal polyps using biomarkers in nasal secretion. Front Immunol. 2022;13:1054201.

Watelet

Bachert

Gevaert

Van Cauwenberge

. Wound healing of the nasal and paranasal mucosa: a review. Am J Rhinol. 2002;16(2):77–84.

Brown

Buzi

Rizzi

. Pediatric endoscopic sinus surgery: postoperative management. Curr Opin Otolaryngol Head Neck Surg. 2025;33.

10.

Bosco

Giai Via

Giustra

Ghirri

Cacciola

Massè

. Platelet-rich plasma for jumper’s knee: a comprehensive review of efficacy, protocols, and future directions. Eur J Orthop Surg Traumatol Orthop Traumatol. 2024;34(1):91–96.

11.

Costa

de Souza

SAL

. The role of injectable platelet-rich fibrin in orthopedics: where do we stand? Curr Issues Mol Biol. 2025;47(4):239.

12.

Proffer

Wyles

Hausauer

. Update on platelet-rich plasma and platelet-rich fibrin for dermatologic surgery: addressing knowns and unknowns. Dermatologic Surg. 2024;50(11s):S149–s159.

13.

Anitua

Fernández-de-Retana

. Platelet rich plasma in oral and maxillofacial surgery from the perspective of composition. Platelets. 2021;32(2):174–182.

14.

Vladulescu

Scurtu

. Platelet-rich plasma (PRP) in dermatology: cellular and molecular mechanisms of action. Biomedicines. 2023;12(1):7.

15.

Dinaki

Grigoriadis

Vizirianakis

Constantinidis

Triaridis

Karkos

. The impact of submucosal PRP injection on wound healing after endoscopic sinus surgery: a randomized clinical trial. Eur Arch Oto-Rhino-Laryngol. 2024;281(7):3587–3599.

16.

Bukhari

Alghamdi

Albeladi

Danish

Alqarni

Almutairi

. Efficacy of platelet-rich plasma in endoscopic sinus surgery for chronic sinusitis: a systematic review and meta-analysis. Cureus. 2024;16(12):e76568.

17.

von Elm

Altman

Egger

. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2007;60(6):344–349.

18.

Fokkens

Lund

Hopkins

, et al. European Position Paper on rhinosinusitis and nasal polyps 2020. Rhinology. 2020;58(Suppl. S29):1–464.

19.

Dohan Ehrenfest

Rasmusson

Albrektsson

. Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF). Trends Biotechnol. 2009;27(3):158–167.

20.

Wang

Avila

. Platelet rich plasma: myth or reality? Eur J Dent. 2007;1(4):192–194.

21.

Bing

Feng

. Acellular dermal matrix contributes to epithelialization in patients with chronic sinusitis. J Biomater Appl. 2019;33(8):1053–1059.

22.

Gutierrez

Bennion

. Vascular pedicled flaps for skull base defect reconstruction. Laryngosc Investig Otolaryngol. 2020;5(6):1029–1038.

23.

Martinez-Paredes

Choby

Marino

, et al. Endoscopic outcomes in patients with AERD treated with topical antibiotics and intranasal corticosteroids. Front Cell Infect Microbiol. 2022;12:812215.

24.

Lund

Kennedy

. Quantification for staging sinusitis. The staging and therapy group. Ann Otol Rhinol Laryngol Suppl. 1995;167:17–21.

25.

Hopkins

Gillett

Slack

Lund

Browne

. Psychometric validity of the 22-item sinonasal outcome test. Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery. 2009;34(5):447–454.

26.

Brown

Lanir

McDonagh

Tognazzi

Dvorak

. Fibroblast migration in fibrin gel matrices. Am J Pathol. 1993;142(1):273–283.

27.

Beule

. Physiology and pathophysiology of respiratory mucosa of the nose and the paranasal sinuses. GMS Curr Top Otorhinolaryngol Head Neck Surg 2010;9:Doc07.

28.

Zhou

Chang

Xing

. Injectable mussel-inspired immobilization of platelet-rich plasma on microspheres bridging adipose micro-tissues to improve autologous fat transplantation by controlling release of PDGF and VEGF, angiogenesis, stem cell migration. Adv Healthc Mater. 2017;6(22):10.

29.

Anitua

Andia

Ardanza

Nurden

. Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb Haemostasis. 2004;91(1):4–15.

30.

Wise

Den Beste

Hoddeson

Parkos

Nusrat

. Sinonasal epithelial wound resealing in an in vitro model: inhibition of wound closure with IL-4 exposure. Int Forum Allergy Rhinol. 2013;3(6):439–449.

31.

Laidlaw

Buchheit

. Biologics in chronic rhinosinusitis with nasal polyposis. Ann Allergy Asthma Immunol. 2020;124(4):326–332.

32.

Tulaci

Yayman

Arslan

, et al. Platelet-rich plasma for rhinitis medicamentosa: a promising histopathological study in an animal model. Otolaryngol–Head Neck Surg. 2025;173(3):754–760.

33.

Zheng

Yang

Lin

Duan

. Hepatocyte growth factor gene-modified mesenchymal stem cells augment sinonasal wound healing. Stem Cells Dev. 2015;24(15):1817–1830.

34.

Mullol

Laidlaw

. Efficacy and safety of dupilumab in patients with uncontrolled severe chronic rhinosinusitis with nasal polyps and a clinical diagnosis of NSAID-ERD: results from two randomized placebo-controlled phase 3 trials. Allergy. 2022;77(4):1231–1244.